Tower Research Capital (TRC)’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Buy |
9,306
+5,672
| +156% | +$184K | 0.01% | 1414 |
|
|
2025
Q1 | $137K | Sell |
3,634
-10,802
| -75% | -$408K | ﹤0.01% | 1597 |
|
|
2024
Q4 | $1.18M | Buy |
14,436
+13,458
| +1,376% | +$1.1M | 0.02% | 551 |
|
|
2024
Q3 | $112K | Sell |
978
-22,557
| -96% | -$2.58M | ﹤0.01% | 2144 |
|
|
2024
Q2 | $1.78M | Buy |
23,535
+22,495
| +2,163% | +$1.7M | 0.03% | 477 |
|
|
2024
Q1 | $71K | Sell |
1,040
-16,509
| -94% | -$1.13M | ﹤0.01% | 2040 |
|
|
2023
Q4 | $1.1M | Buy |
17,549
+16,386
| +1,409% | +$1.03M | 0.01% | 791 |
|
|
2023
Q3 | $59.3K | Sell |
1,163
-3,500
| -75% | -$178K | ﹤0.01% | 2403 |
|
|
2023
Q2 | $233K | Buy |
4,663
+2,166
| +87% | +$108K | 0.01% | 1440 |
|
|
2023
Q1 | $94K | Buy |
2,497
+1,755
| +237% | +$66.1K | ﹤0.01% | 1930 |
|
|
2022
Q4 | $35K | Sell |
742
-7,200
| -91% | -$340K | ﹤0.01% | 2615 |
|
|
2022
Q3 | $191K | Sell |
7,942
-453
| -5% | -$10.9K | ﹤0.01% | 1982 |
|
|
2022
Q2 | $183K | Buy |
8,395
+7,416
| +758% | +$162K | ﹤0.01% | 1829 |
|
|
2022
Q1 | $23K | Sell |
979
-648
| -40% | -$15.2K | ﹤0.01% | 3399 |
|
|
2021
Q4 | $38K | Buy |
1,627
+57
| +4% | +$1.33K | ﹤0.01% | 3006 |
|
|
2021
Q3 | $40K | Sell |
1,570
-890
| -36% | -$22.7K | ﹤0.01% | 3129 |
|
|
2021
Q2 | $55K | Sell |
2,460
-424
| -15% | -$9.48K | ﹤0.01% | 2952 |
|
|
2021
Q1 | $57K | Buy |
2,884
+732
| +34% | +$14.5K | ﹤0.01% | 3008 |
|
|
2020
Q4 | $57K | Sell |
2,152
-609
| -22% | -$16.1K | ﹤0.01% | 2976 |
|
|
2020
Q3 | $136K | Buy |
+2,761
| New | +$136K | ﹤0.01% | 2901 |
|